• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 49

Substance: Bifidobacterium lactis strain Bb12 and Streptococcus thermophilus strain Th4
Intended Use: Ingredients in milk-based infant formula that is intended for consumption by infants four months and older, at levels not to exceed good manufacturing practice
Basis: Scientific procedures
Notifier: Nestle USA
800 North Brand Boulevard; Glendale, CA 91203
Date of filing: Jun 14, 2000
GRAS Notice (releasable information): 49 Part 1
49 Part 2
Date of closure / FDA's Letter: Mar 19, 2002
FDA has no questions (additional correspondence available)
Additional correspondence: Additional correspondence clarifying new information on B. lactis strain Bb12: Nov. 28, 2005